No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission

Neurogastroenterology and Motility

Volumn 19, Issue 11, 2007, Pages 896-904

  Karling, P ^a   Danielsson, A ^a   Adolfsson, R ^b,c   Norrback, K F ^b,c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Hospital of Sunderbyn   (Sweden)

Author keywords

Antidepressant; Brain gut axis; Gastro intestinal symptoms; Hospital Anxiety and Depression Scale; Irritable bowel syndrome; Recurrent depression

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; PAIN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HEALTH SURVEYS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; REMISSION, SPONTANEOUS; SEVERITY OF ILLNESS INDEX;

EID: 35848950728     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2007.00967.x     Document Type: Article

References (60)

1. Drossman DA, Camilleri M, Mayer E, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002 123 : 2108 213.
2. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991 101 : 927 34.
3. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002 47 : 225 35.
4. Lea R, Whorwell PJ. New insights into the pshychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep 2003 5 : 343 50.
5. Mayer EA, Craske M, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 2001 62 (Suppl. 8 28 36.
6. Blanchard EB, Scharff L, Schwarz SP, Suls JM, Barlow DH. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 1990 28 : 401 5.
7. Walker EA, Katon WJ, Jemelka RP, Roy-Bryne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) study. Am J Med 1992 92 (Suppl. 1A 26 30.
8. Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry 1990 147 : 1656 61.
9. Toner BB, Garfinkel PE, Jeejeebhoy KN. Psychological factors in irritable bowel syndrome. Can J Psychiatry 1990 35 : 158 61.
10. MacDonald AJ, Bouchier IA. Non-organic gastrointestinal illness: a medical and psychiatric study. Br J Psychiatry 1980 136 : 276 83.
11. Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991 100 : 450 7.
12. Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 1993 34 : 229 34.
13. Guthrie EA, Creed FH, Whorwell PJ, Tomenson B. Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders. Gut 1992 33 : 361 3.
14. Blewett A, Allison M, Calcraft B, Moore R, Jenkins P, Sulivan G. Psychiatric disorder and outcome in irritable bowel syndrome. Psychosomatics 1996 37 : 155 60.
15. Blanchard EB, Schwarz SP, Payne A, Schwarz SP, Suls JM, Malamood H. Prediction of outcome from cognitive behavioural treatment of irritable bowel syndrome. Behav Res Ther 1992 30 : 647 50.
16. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002 51 : 410 3.
17. Lancaster-Smith MJ, Prout BJ, Pinto T, Anderson JA, Schiff AA. Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand 1982 66 : 33 41.
18. Blanchard EB, Schwarz SP, Neff DF, Geradi MA. Prediction of outcome from the self-regulatory treatment of irritable bowel syndrome. Behav Res Ther 1988 26 : 187 90.
19. Talley NJ, Howell S, Poulton R. The Irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol 2001 96 : 1072 9.
20. Dinan TG, Quigley EMM, Ahmed SMM et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006 130 : 304 11.
21. Tollefson GD, Tollefson SL, Pederson M, Luxenberg M, Dunsmore G. Comorbid irritable bowel syndrome in patients with. generalized anxiety and major depression. Ann Clin Psychiatry 1991 3 : 215 22.
22. Masand P, Kaplan D, Gupta S et al. Major depression and irritable bowel syndrome: is there a relationship? J Clin Psychiatry 1995 56 : 363 7.
23. Masand P, Kaplan D, Gupta S, Bhandary A, Nasra G. Irritable bowel syndrome and dysthymia: is there a relationship? Psychosomatics 1997 38 : 63 9.
24. Kaplan D, Masand P, Gupta S. The relationship of irritable bowel syndrome and panic disorder. Ann Clin Psychiatry 1996 8 : 81 8.
25. Noyes R, Cook B, Garvey M, Summers R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990 31 : 75 9.
26. Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology 2000 33 : 307 9.
27. Gerber PD, Barrett JA, Oxman TE, Manheimer E, Smith R, Whiting RD. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992 7 : 170 3.
28. Cadoret RJ, Widmer RB, North C. Depression in family practice: long-term prognosis and somatic complaints. J Fam Pract 1980 10 : 625 9.
29. Hefner JD, Wilder RM, Wilson ID. Irritable colon and depression. Psychosomatics 1978 19 : 540 7.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC, USA : American Psyciatric Association, 1994.
31. Nilsson L-G, Bäckman L, Erngrund K et al. The Betula prospective cohort study: memory, health, and aging. Aging Neuropsychol Cogn 1997 4 : 1 32.
32. Brändström S, Schlette P, Przybeck T et al. Swedish normative data on personality using the temperament and character inventory. Compr Psychiatry 1998 39 : 122 8.
33. Chotai J, Forsgren T, Nilsson L-G, Adolfsson R. Season of birth variations in the temperament and character inventory of personality in a general population. Neuropsychobiology 2001 44 : 19 26.
34. Chotai J, Smedh K, Nilsson LG, Adolfsson R. A dual vulnerability hypothesis for seasonal depression is supported by the seasonal pattern assessment questionnaire in relation to the temperament and character inventory of personality in a general population. J Affect Disord 2004 82 : 61 70.
35. Wiklund IK, Fullerton S, Hawkey J et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003 9 : 947 54.
36. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993 28 : 681 7.
37. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983 67 : 361 70.
38. Herrmann C. International experience with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997 42 : 17 41.
39. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An update literature review. J Psychosom Res 2002 52 : 69 77.
40. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999 45 (Suppl. II S43 7.
41. Drossman DA. Psychosocial factors and the disorders of GI function: what is the link? Am J Gastroenterol 2004 99 : 358 60.
42. Creed FH. Psychopathology of functional disorders of the gut. In : Phillips SF, Wingate DL, eds. Functional Disorders of the Gut: A Handbook for Clinicans. London : WB Sauncers Co, 1998 : 71 97.
43. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999 44 : 400 6.
44. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant mediciations: a meta-analysis. Am J Med 2000 108 : 65 72.
45. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000 47 : 861 9.
46. Mayer EA, Fanselow MS. Dissecting the components of the central response to stress. Nat Neurosci 2003 6 : 1011 2.
47. Claes SJ. CRH, stress, and major depression: a psychobiological interplay. Vitam Horm 2004 69 : 117 50.
48. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotrophin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001 280 : G173 7.
49. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and in patients with irritable bowel syndrome. Gut 1998 42 : 845 9.
50. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002 122 : 1140 56.
51. Levy RL, Whitehead WE, Von Korff MR, Feld AD. Intergenerational transmission of gastrointestinal illness behaviour. Am J Gastrenterol 2000 95 : 451 6.
52. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999 354 : 936 9.
53. Fava M. Depression with physical symptoms: treating to remission. J Clin Psychiatry 2003 64 (Suppl. 7 24 8.
54. Lepine JP, Briley M. The epidemiology of pain in depression. Hum Psychopharmacol 2004 19 (Suppl. 1 S3 7.
55. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 2000 1 : 310 6.
56. Stahl S, Briely M. Understanding pain in depression. Hum Psychopharmacol 2004 19 (Suppl. S9 13.
57. Broekaert D, Gevers A, Janssens J. A double blind randomized placebo controlled crossover trial of citalopram, a selective 5-hytroxytryptamine reuptake inhibitor, in irritable bowel syndrome (abstract). Gastroenterology 2001 120 (Suppl. 1 3250.
58. Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers A, Janssens J. A controlled cross-over study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 2006 55 : 1095 103.
59. Creed F, Fernandes L, Guthrie E et al. North of England IBS Research Group. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003 124 : 303 17.
60. Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 2003 3 : 219 28.